A coalition of leading U.S. racetracks and racing organizations have announced a landmark initiative, phasing out the use of Furosemide (Lasix) beginning in 2-year-old-racing in January 2020 and eliminating the use of Lasix in black-type races held at their racetracks beginning the following year.

The coalition includes all tracks owned and operated by Churchill Downs Inc., the New York Racing Association and The Stronach Group as well as Del Mar, Keeneland, Lone Star Park, Remington Park, Los Alamitos (Thoroughbred), Oaklawn Park and Tampa Bay Downs.

Taken together, those tracks account for 86% of stakes races assigned listed or graded status in the United States. Breeders’ Cup Ltd., the Thoroughbred Owners and Breeders Association (TOBA), the American Graded Stakes Committee of TOBA and the Kentucky Thoroughbred Association (KTA) have also pledged their support to the initiative.


This site uses Akismet to reduce spam. Learn how your comment data is processed.